Ha-ras oncogene-induced Stat3 phosphorylation enhances oncogenicity of the cell

DNA and Cell Biology

Volumn 28, Issue 3, 2009, Pages 131-139

  Yeh, Hsuan Heng ^a   Giri, Raghavaraju ^a   Chang, Tsuey Yu ^a   Chou, Cheng Yang ^a,b   Su, Wu Chou ^a,b,c   Liu, Hsiao Sheng ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CYCLIN D1; INTERLEUKIN 6; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLADDER; CANCER CELL; CARCINOGENESIS; CARCINOGENICITY; CELL STRUCTURE; COLONY FORMATION; CONTROLLED STUDY; DNA BINDING; EMBRYO; FEMALE; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SERUM; TRANSCRIPTION INITIATION; TUMOR GROWTH; TUMOR XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; GENES, RAS; HUMANS; INTERLEUKIN-6; LUNG NEOPLASMS; MICE; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; SERINE; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; URINARY BLADDER NEOPLASMS;

MUS;

EID: 62249214235     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2008.0762     Document Type: Article

References (51)

1. Abe, K., Hirai, M., Mizuno, K., Higashi, N., Sekimoto, T., Miki, T., Hirano, T., and Nakajima, K. (2001). The YXXQ motif in gp 130 is crucial for STAT3 phosphorylation at Ser727 through an H7-sensitive kinase pathway. Oncogene 20, 3464-3474.
2. Aziz, M.H., Manoharan, H.T., Church, D.R., Dreckschmidt, N.E., Zhong, W., Oberley, T.D., Wilding, G., and Verma, A.K. (2007). Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer. Cancer Res 67, 8828-8838.
3. Bos, J.L. (1989). ras oncogenes in human cancer: a review. Cancer Res 49, 4682-4689.
4. Boulton, T.G., Zhong, Z., Wen, Z., Darnell, J.E., Jr., Stahl, N., and Yancopoulos, G.D. (1995). STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proc Natl Acad Sci USA 92, 6915-6919.
5. Bowman, T., Garcia, R., Turkson, J., and Jove, R. (2000). STATs in oncogenesis. Oncogene 19, 2474-2488.
6. Bromberg, J.F. (2001). Activation of STAT proteins and growth control. Bioessays 23, 161-169.
7. Bromberg, J., and Darnell, J.E., Jr. (2000). The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19, 2468-2473.
8. Bromberg, J.F., Wrzeszczynska, M.H., Devgan, G., Zhao, Y., Pestell, R.G., Albanese, C., Darnell, J.E., Jr. (1999). Stat3 as an oncogene. Cell 98, 295-303.
9. Catlett-Falcone, R., Landowski, T.H., Oshiro, M.M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J.L., Nuñez, G., Dalton, W.S., and Jove, R. (1999). Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10, 105-115.
10. Ceresa, B.P., Horvath, C.M., and Pessin, J.E. (1997). Signal transducer and activator of transcription-3 serine phosphorylation by insulin is mediated by a Ras/Raf/MEK-dependent pathway. Endocrinol 138, 4131-4137.
11. Chang, T.Y., Wen, Y.Y., Yeh, H.H., Wang, S.T., Su, I.J., and Liu, H.S. (1999). Plasmid harboring lac repressor and tTA activator genes can regulate two inducible genes in mammalian cells. Biotechniques 27, 466-469.
12. Chung, J., Uchida, E., Grammer, T.C., and Blenis, J. (1997). STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol 17, 6508-6516.
13. Coffer, P.J., Koenderman, L., and de Groot, R.P. (2000). The role of STATs in myeloid differentiation and leukemia. Oncogene 19, 2511-2522.
14. Darnell, J.E., Jr. (1997). STATs and gene regulation. Science 277, 1630-1635.
15. Darnell, J.E., Jr. (1998). Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway. J Interferon Cytokine Res 18, 549-554.
16. Dearolf, C.R. (1999). JAKs and STATs in invertebrate model organisms. Cell Mol Life Sci 55, 1578-1584.
17. Garcia, R., and Jove, R. (1998). Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J Biomed Sci 5, 79-85.
18. Hirano, T., Ishihara, K., and Hibi, M. (2000). Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19, 2548-2556.
19. Ihle, J.N. (1995). Cytokine receptor signalling.Nature 377, 591-594.
20. Jain, N., Zhang, T., Fong, S.L., Lim, C.P., and Cao, X. (1998). Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK). Oncogene 17, 157-167.
21. Jain, N., Zhang, T., Kee, W.H., Li, W., and Cao, X. (1999). Protein kinase C delta associates with and phosphorylates Stat3 in an interleukin-6-dependent manner. J Biol Chem 274, 24392-24400.
22. Kelley, G.G., Reks, S.E., Ondrako, J.M., and Smrcka, A.V. (2001). Phospholipase C(epsilon): a novel Ras effector. EMBO J 20, 743-754.
23. Kotenko, S.V., and Pestka, S. (2000). Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene 19, 2557-2565.
24. Kuroki, M., and O'Flaherty, J.T. (1999). Extracellular signal-regulated protein kinase (ERK)- dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines. Biochem J 341, 691-696.
25. Leevers, S.J., Paterson, H.F., and Marshall, C.J. (1994). Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369, 411-414.
26. Levy, D.E., and Darnell, J.E., Jr. (2002). Stats: transcriptional control and biological impact. Nature Rev Mol Cell Biol 3, 651-662.
27. Levy, D.E., and Lee, C.K. (2002). What does Stat3 do? J Clin Invest 109, 1143-1148.
28. Lim, C.P., and Cao, X. (1999). Serine phosphorylation and negative regulation of Stat3 by JNK. J Biol Chem 274, 31055-31061.
29. Liu, H.S., Scrable, H., Villaret, D.B., Lieberman, M.A., and Stambrook, P.J. (1992). Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements. Cancer Res 52, 983-989.
30. Liu, H.S., Chen, C.Y., Lee, C.H., and Chou, Y.I. (1998a). Selective activation of oncogenic Ha-ras-induced apoptosis in NIH/3T3 cells. Br J Cancer 77, 1777-1786.
31. Liu, J.J., Chao, J.R., Jiang, M.C., Ng, S.Y., Yen, J.J., and Yang-Yen, H.F. (1995). Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol Cell Biol 15, 3654-3663.
32. Liu, J.J., Nakajima, K., Hirano, T., and Yang-Yen, H.F. (1998b). Activation of Stat3 by v-Src is through a Ras-independent pathway. J Biomed Sci 5, 446-450.
33. Lufei, C., Koh, T.H., Uchida, T., and Cao, X. (2007). Pin1 is required for the ser727 phosphorylation-dependent Stat3 activity. Oncogene 26, 7656-7664.
34. Ng, J., and Cantrell, D. (1997). STAT3 is a serine kinase target in T lymphocytes. Interleukin 2 and T cell antigen receptor signals converge upon Serine-727. J Biol Chem 272, 24542-24549.
35. 727 phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity and transformation. J Biol Chem 82, 6415-6424.
36. Qin, H.R., Kim, H.J., Kim, J.Y., Hurt, E.M., Klarmann, G.J., Kawasaki, B.T., Duhagon Serrat, M.A., and Farrar, W.L. (2008). Activation of signal transducer and activator of transcription 3 through a phosphomimetic Serine-727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation. Cancer Res 68, 7736-7741.
37. Rodriguez-Viciana, P., Warne, P.H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M.J., Waterfield, M.D., and Downward, J. (1994). Phosphatidylinositol- 3-OH kinase as a direct target of Ras. Nature 370, 527-532.
38. Sebti, S.M., and Der, C.J. (2003). Opinion: searching for the elusive targets of farnesyltransferase inhibitors. Nature Rev Cancer 3, 945-951.
39. Shi, X., Zhang, H., Paddon, H., Lee, G., Cao, X., and Pelech, S. (2006). Phosphorylation of STAT3 serine-727 by cyclin-dependent kinase 1 is critical for nocodazole-induced mitotic arrest. Biochemistry 45, 5857-5867.
40. Shields, J.M., Pruitt, K., McFall, A., Shaub, A., and Der, C.J. (2000). Understanding Ras: "it ain't over 'til it's over." Trends Cell Biol 10, 147-154.
41. Sinibaldi, D., Wharton, W., Turkson, J., Bowman, T., Pledger, W.J., and Jove, R. (2000). Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene 19, 5419-5427.
42. Takai, Y., Sasaki, T., and Matozaki, T. (2001). Small GTP-binding proteins. Physiol Rev 81, 153-208.
43. Turkson, J., Bowman, T., Adnane, J., Zhang, Y., Djeu, J.Y., Sekharam, M., Frank, D.A., Holzman, L.B., Wu, J., Sebti, S., and Jove, R. (1999). Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol Cell Biol 19, 7519-7528.
44. Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., De Groot, R.P., and Jove, R. (1998). Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol 18, 2545-2552.
45. Turkson, J., and Jove, R. (2000). STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 19, 6613-6626.
46. Venkatasubbarao, K., Choudary, A., and Freeman, J.W. (2005). Farnesyl transferase inhibitor (R115777)-induced inhibition of STAT3 (Tyr705) phosphorylation in human pancreatic cancer cell lines require extracellular signal-regulated kinases. Cancer Res 65, 2861-2871.
47. Wen, Z., Zhong, Z., and Darnell, J.E., Jr. (1995). Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241-250.
48. Yeh, H.H., Lai, W.W., Chen, H.H., Liu, H.S., and Su, W.C. (2006). Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. Oncogene 25, 4300-4309.
49. Yeh, H.H., Wu, C.H., Giri, R., Kato, K., Khono, K., Izumi, H., Chou, C.Y., Su, W.C., and Liu, H.S. (2008). Oncogenic Ras-induced morphologic change is through MEK/ERK signaling pathway to downregulate stat3 at a posttranslational level in NIH3T3 cells. Neoplasia 10, 52-60.
50. Yokogami, K., Wakisaka, S., Avruch, J., and Reeves, S.A. (2000). Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr Biol 10, 47-50.
51. Zushi, S., Shinomura, Y., Kiyohara, T., Miyazaki, Y., Kondo, S., Sugimachi, M., Higashimoto, Y., Kanayama, S., and Matsuzawa, Y. (1998). STAT3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells. Int J Cancer 78, 326-330.